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Only few years ago, scientists had to struggle to convince audiences and editors that cell metabolism
and biochemistry were not boring, let alone persuade the scientific community that alterations of
the metabolic machinery could underpin human diseases (1). We hear from more senior scientists
(we were only undergraduate students at the time, more often than not dreading our studies of
glycolysis, Krebs cycle, electron transport chain, etc., on the “famous” Lehninger text-book) that
publishing the first paper on c-Myc-mediated transcriptional control of the metabolic enzyme
lactate dehydrogenase as a key mechanism for cancer transformation (2) or lymphocyte survival
and activation via TCR-dependent regulation of nutrient uptake and utilization (3, 4) was not easy
at all. Indeed, they had to overcome the preconception of a well-established scientific community
that, for the last few decades, had believed in the supremacy of molecular biology and genetics as
experimental tools for understanding cellular mechanisms and disease processes.
In 2015, metabolism is the heart of an ever growing body of studies, spanning the fields of cancer,
stem cells, and, as highlighted in this series of review articles, immunology and metabolic diseases.
This unexpected renaissance in the field of metabolism stands on the shoulders of giants. Indeed,
scientists of the caliber of Warburg, Krebs, and Mitchell, just to name a few, spent their entire lives
exploring the intricacies of cellmetabolism.Not only had they elucidated the pathways for utilization
of glucose and other nutrients for the generation of ATP but had also initiated the modern and
fashionable concept of integration of metabolic processes with diseases and immune-regulation.
As described by Nagy and Haschemi (5), Kempner and Peschel proposed the idea of a tight link
between metabolism and inflammation, the modern so-called immunometabolism, as far back as
1930s. Unfortunately, the whole field ofmetabolismwas relegated to themargins ofmodern research
for long time, being considered irrelevant for addressing more important questions, such as how
proliferation, differentiation, and cell death, are regulated in the cell. This obnubilation lasted until
the realization that all these processes have distinct metabolic requirements and that impairing
metabolism could perturb them. We now know that signaling pathways directly control specific
metabolic pathways and enzymes, and vice versa, and even more astonishingly, that intermediates
of metabolism, such as lactate or succinate, or metabolic enzymes (i.e., GAPDH or PFKFB3)
can regulate gene expression, protein translation, or indeed entire processes, such as endothelial
sprouting.
The studies on immunometabolism that we present here encompass both cellular and systemic
aspects of disease. At a cellular level, immunometabolism studies show how intracellular metabolic
pathways activated downstream of growth factors and cytokines control immune cell functions. On
an organismal level, immunometabolism investigates how immune cells regulate the homeostasis of
metabolic tissues and how they contribute to the process of metabolic diseases, including obesity
and type II diabetes. This collection contains 10 review articles that cover important and emerging
aspects in both of these branches of immunometabolism.
At the cellular level, Howie et al. (6) focus on the mechanisms of nutrient sensing in T cells and
how these integrate with TCR and cytokine signals via the mTOR pathway to determine distinct
differentiation pathways toward effector or regulatory T cell (Treg) subsets. Going deeper into the
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biology of Treg lymphocytes, Coe et al. (7) describe recent findings
on the unique metabolic needs of Treg as compared to effector
T cells (Teff), with a particular focus on mTOR-mediated control
of metabolism in these T cell subsets. Schurich and Henson (8)
discuss the emerging view that as a consequence of viral infec-
tion and antigenic load, CD8+ T cells can become senescent
or exhausted. These are distinct fates of a T cell, sustained by
different metabolic programs, which in turn dictate opposing
outcomes during immune responses. Nagy and Haschemi (5)
illustrate the metabolic changes that take place in macrophages
upon LPS-induced activation and polarization. They then focus
on how the pentose phosphate pathway is regulated during LPS-
versus IL-4-induced polarization of macrophages and may be of
importance in the provision of both nucleotide precursors and
redox-equivalents determining different cell fates and types of
immune response. Finally, Jones and Bianchi (9) give an overview
of some recent key examples of metabolic control of biological
processes beyond cellular proliferation. In particular, the roles of
intermediates of metabolism in the control of gene expression,
of metabolic enzymes in the regulation of protein translation
and cellular differentiation, and of aerobic glycolysis in epigenetic
determination of trained immunity are discussed.
At a more systemic level, Wang et al. (10) offer their views
on the possible interplay between tumor cells and immune cells
in the tumor microenvironment. Tumor cells may compete for
nutrients with some immune cells, thereby compromising their
function. Tumor cells may also become metabolically symbiotic
with other immune cells, which in turn may provide signals
for tumor growth. Gerriets and MacIver (11) overview the well-
established link between nutritional status and immune cell func-
tion. They pay particular attention to the signals linking nutrient
stress to T cell metabolic adaptation and how this crosstalk may
result in low-grade inflammation leading to metabolic syndrome
as a consequence of obesity or increased risk of mortality by
infectious diseases as a consequence of malnutrition. The con-
nection between immune cells and metabolic diseases is further
discussed by Capasso et al. (12), who ask questions about the
possible crosstalk of B cells with the adipose tissue in homeostatic
conditions and during obesity; however, this field is currently
understudied, leaving us with more questions than answers. Con-
tinuing on the same issue, Mauro et al. (13) discuss the clinical
evidence of the association that exists between increased incidence
of obesityworldwide and increased prevalence and severity of cog-
nitive disorders. They speculate that systemic metabolic imbal-
ance can have direct consequences on the integrity and function
of the blood–brain barrier, thereby leading to the insurgence of
cerebrovascular and neurodegenerative pathologies; however, the
mechanistic links are unknown at present. Finally, Tannahill et al.
(14) discuss the importance of macrophages in the pathogenesis
of multiple sclerosis, the metabolic changes behind macrophage
polarization, and how macrophage metabolic re-education could
be used in the future for the treatment of multiple sclerosis.
In conclusion, these are exciting times for the discovery of
the many mechanisms of integration between metabolic and sig-
naling pathways as ways to determine cell fates and types of
immune response. These are also exciting times for those who are
investigating the metabolic crosstalk between immune cells and
stromal cells during homeostasis and in diseased tissues. We are
hopeful that gaining deeper understanding of how metabolism
and signaling pathways coordinate with each other will lead to
new perspectives on disease mechanisms and, ultimately, to the
development of novel therapeutic tools.
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